candesartan cilexetil has been researched along with ng-nitroarginine methyl ester in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T; Iwai, J; Kanayama, Y; Konishi, Y; Negoro, N; Nishimura, M; Okamura, M; Takeda, T; Umetani, N | 1 |
| Fujita, H; Itoh, H; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Tanaka, M; Uchida, A | 1 |
| Fujita, H; Itoh, H; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Takenaka, K; Uchida, A | 1 |
| Hashimoto, S; Kawata, T; Koike, T | 1 |
| Artuso, A; Benahmed, S; Casellas, D; Jover, B | 1 |
| Ardaillou, R; Chansel, D; Henrion, D; Levy, BI; Loufrani, L | 1 |
| Egashira, K; Katoh, M; Mitsui, T; Narita, H; Takeshita, A | 1 |
| Fujimura, A; Sugimoto, K; Tsuruoka, S | 1 |
| Egashira, K; Inoue, S; Kaibuchi, K; Kataoka, C; Kitamoto, S; Koyanagi, M; Ni, W; Shimokawa, H; Takemoto, M; Takeshita, A; Usui, M | 1 |
| Ishiguro, K; Itoh, H; Sakamaki, Y; Saruta, T; Sasamura, H | 1 |
| Bucas, V; Desfontis, JC; Gogny, M; Mallem, MY; Noireaud, J; Sauvaget, F | 1 |
| Azegami, T; Hayashi, K; Itoh, H; Sasamura, H | 1 |
12 other study(ies) available for candesartan cilexetil and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Evaluation Studies as Topic; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prodrugs; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles | 1994 |
Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Coronary Circulation; Coronary Vessels; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Vascular Resistance | 1994 |
Role of nitric oxide in impaired coronary circulation and improvement by angiotensin II receptor antagonist in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Enzyme Inhibitors; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1995 |
Effects of chronic nitric oxide synthase inhibition on renal function and histology in polycythemic rats.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Enzyme Inhibitors; Erythropoietin; Follow-Up Studies; Glomerular Filtration Rate; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Polycythemia; Prodrugs; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tetrazoles | 1998 |
Candesartan and progression of preglomerular lesions in N(G)-nitro-L-arginine methyl ester hypertensive rats.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1999 |
Functional evidence for an angiotensin IV receptor in rat resistance arteries.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Drug Interactions; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Perfusion; Phenylephrine; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Serotonin; Tachyphylaxis; Tetrazoles; Vascular Resistance | 1999 |
Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat hearts.
Topics: Actins; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Gene Expression Regulation; Heart; Imidazoles; Imidazolidines; Immunohistochemistry; Male; Muscle, Skeletal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles | 2000 |
Effect of prolonged nitric oxide synthesis inhibition on plasma fibrinogen concentration in rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Fibrinogen; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tetrazoles | 2001 |
Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
Topics: Actins; Amides; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Chemokine CCL2; Coronary Vessels; Enzyme Inhibitors; Hydralazine; Immunohistochemistry; Inflammation; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Muscle, Smooth; Myosins; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred WKY; rho-Associated Kinases; RNA, Messenger; Superoxide Dismutase; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Topics: Aging; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Cardiovascular System; Critical Period, Psychological; Drug Administration Schedule; Enzyme Inhibitors; Hypertension; Kidney; Male; Mortality; NG-Nitroarginine Methyl Ester; Oxidative Stress; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles; Vasoconstrictor Agents | 2007 |
Positive influence of AT(1) receptor antagonism upon the impaired celiprolol-induced vasodilatation in aorta from spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Celiprolol; Dose-Response Relationship, Drug; Endothelium, Vascular; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tetrazoles; Vasodilation; Vasodilator Agents | 2010 |
Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Enzyme Inhibitors; Hydralazine; Kidney Diseases; Kidney Glomerulus; Male; Membrane Proteins; NG-Nitroarginine Methyl Ester; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Tetrazoles; Vaccines | 2012 |